Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Methamphetamine

5

XII.f Cardiomyopathy (acute, subacute, chronic)

2
Last update : 30/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Amphetamine (and -derivatives)
3
Body packing
4
Ephedrine
1
Gases
5
Paramethoxymethamphetamine
1
Phosphine (H3P)
3
Pseudoephedrine
1
Recreational drugs
5
Stimulants, psychostimulants, psychoactive substances
5

Publications

Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.
Heart, lung & circulation 2022 May;31;616-622 2022 May
Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.
JACC. Heart failure 2017 Jun;5;435-445 2017 Jun
The unique histology of methamphetamine cardiomyopathy: a case report.
Forensic science international 2011 Oct 10;212;e1-4 2011 Oct 10
Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
Addiction (Abingdon, England) 2008 Aug;103;1353-60 2008 Aug
The association of methamphetamine use and cardiomyopathy in young patients.
The American journal of medicine 2007 Feb;120;165-71 2007 Feb
Cardiomyopathy associated with the smoking of crystal methamphetamine.
JAMA 1991 Mar 06;265;1152-4 1991 Mar 06

Powered by

  • ^
  • Contact
  • Cookies
  • About